Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate whether treatment with a combination capsule of Esomeprazole 40 mg and Aspirin (ASA) 325 mg is bioequivalent (i.e.has the same effect within the body) as these medications taken separately. Two different forms of esomeprazole (tablets and capsules) will be investigated.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label


Related Conditions & MeSH terms


NCT number NCT00998075
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 1
Start date September 2009
Completion date December 2009

See also
  Status Clinical Trial Phase
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Completed NCT02716025 - Serum Zinc, Peptic Ulcer Disease and H. Pylori Infection N/A
Terminated NCT01015729 - Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately Phase 1
Completed NCT02165488 - Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae
Recruiting NCT03320538 - Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases N/A
Completed NCT02332213 - Volatile Markers in Digestive Cancer
Completed NCT05618249 - Inventory of Inappropriate Prescriptions of Proton Pump Inhibitors (PPIs) in People Over 75 Years of Age
Completed NCT04918472 - Minimally Invasive Evaluation of Dyspepsia by Combined Magnetically Controlled Capsule Endoscopy and Urea Breath Test: a Pilot Prospective Cohort Study N/A